Recombinant adenoviruses with large deletions generated by Cre-mediated excision exhibit different biological properties compared with first- generation vectors in vitro and in vivo

Journal of Virology

Volumn 70, Issue 12, 1996, Pages 8944-8960

  Lieber, André ^a   He, Cheng Yi ^a   Kirillova, Irina ^a   Kay, Mark A ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINASE; VIRUS PROTEIN; VIRUS VECTOR;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; GENE DELETION; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENE; VIRUS GENE; VIRUS RECOMBINANT;

EID: 0029861452     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.12.8944-8960.1996     Document Type: Article

References (66)

1. Akira, S., H. Isshiki, T. Sugita, O. Tanabe, S. Kinoshita, Y. Nishio, T. Nakajima, and T. Kishimoto. 1990. A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family. EMBO J. 9:1897-1906.
2. Armentano, D., C. C. Sookdeo, K. M. Hehir, R. J. Gregory, J. A. St. George, G. A. Prince, S. C. Wadsworth, and A. E. Smith. 1995. Characterization of an adenovirus gene transfer vector containing an E4 deletion. Hum. Gene Ther. 6:1343-1353.
3. Barr, D., J. Tubb, D. Ferguson, A. Scaria, A. Lieber, C Wilson, J. Perkins, and M. A. Kay. 1995. Strain related variations in adenovirally mediated transgene expression from mouse hepatocytes in vivo: comparison between immunocompetent and immunodeficient inbred strains. Gene Ther. 2:151-155.
4. Berker, K. L. 1988. Development of adenovirus vectors for the expression of heterologous genes. BioTechniques 6:616-624.
5. Bett, A. J., W. Haddara, L. Prevec, and F. L. Graham. 1994. An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3. Proc. Natl. Acad. Sci. USA 91:8802-8806.
6. Boucher, R. C. 1996. Current status of CF gene therapy. Trends Genet. 12:81-84.
7. Brody, S. L., M. Metzger, C. Danel, M. A. Rosenfeld, and R. G. Crystal. 1994 Acute response of non-human primates to airway delivery of an adenovirus vector containing the human cystic fibrosis transmembrane conductance regulator cDNA. Hum. Gene Ther. 5:821-836.
8. Crystal, R. G., N. G. McElvaney, M. A. Rosenfeld, C.-S. Chu, A. Mastrangeli, J. G. Hay, S. L. Brody, H. A. Jaffe, N. T. Eissa, and C. Danel. 1994. Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nature (London) Gent. 8:42-51.
9. Daniell, E., D. E. Groff, and M. J. Fedor. 1981. Adenovirus chromatin structure at different stages of infection. Mol. Cell. Biol. 1:1094-1105.
10. D'ery, C. V., M. Toth, M. Brown, J. Horvath, S. Allaire, and J. M. Weber. 1985. The structure of adenovirus chromatin in infected cells. J. Gen. Virol. 66:2671-2684.
11. Dooley, T. P., M. Miranda, N. C. Jones, and M. L. DePamphilis. 1990. Transactivation of the adenovirus EIIa promoter in the absence of adenovirus E1a protein is restricted to mouse oocytes and preimplantation embryos. Development 107:945-956.
12. Duncan, S. J., F. C. A. Gordon, D. W. Gregory, J. L. McPhie, R. Postlethwaite, R. White, and H. N. A. Willcox. 1978. Infection of mouse liver by human adenovirus type 5. J. Gen. Virol. 40:45-61.
13. Engelhardt, J. F., L. Litzky, and J. M. Wilson. 1994. Prolonged transgene expression in cotton rat lung with recombinant adenoviruses defective in E2a. Hum. Gene Ther. 4:759-769.
14. Engelhardt, J. F., R. H. Simon, Y. Yang, M. Zepeda, S. Weber Pendleton, B. Doranz, M. Grossman, and J. M. Wilson. 1993. Direct gene transfer of human CFTR into human bronchial epithelia of xenografts with E1-deleted adenoviruses. Nature (London) Genet. 4:27-34.
15. Fang, B., R. C. Eisensmith, X. H. C. Li, M. J. Finegold, A. Shedlovsky, W. Dove, and S. L. C. Woo. 1996. Lack of persistence of E1 recombinant adenoviral vectors containing a temperature-sensitive E2a mutation in immunocompetent mice and hemophilia B dogs. Gene Ther. 3:217-222.
16. Fausto, N., and E. M. Webber. 1994. Regeneration in the liver: biology and pathobiology, p. 1059-1084. In I. M. Arias, J. L. Boyer, N. Fausto, W. B. Jacoby, D. Schachter, and D. A. Shafritz (ed.), The liver: biology and pathobiology. Raven, New York.
17. Fisher, K. J., H. Choi, J. Burda, S.-J. Chen, and J. M. Wilson. 1996 Recombinant adenovirus deleted of all genes for genes therapy of cystic fibrosis. Virology 217:11-22.
18. Fredman, J. N., and J. A. Engler. 1993. Adenovirus precursor to terminal protein interacts with the nuclear matrix in vivo and in vitro. J. Virol. 67:3384-3395.
19. Ginsberg, H. S., R. L. Horswood, R. M. Chanock, and G. A. Prince. 1990. Role of early genes in pathogenesis of adenovirus pneumonia. Proc. Natl. Acad. Sci. USA 87:6191-6195.
20. Ginsberg, H. S., L. L. Moldawer, P. B. Sehgal, M. Redington, P. L. Kilian, R. M. Chanock, and G. A. Prince. 1991. A mouse model for investigating the molecular pathogenesis of adenovirus pneumonia. Proc. Natl. Acad. Sci. USA 88:1651-1655.
21. Gorziglia, M. I., M. J. Kadan, Y. Soonpin, J. Lim, G. M. Lee, R. Luthra, and B. C. Trapnell. 1996. Elimination of both E1 and E2a from adenovirus vectors further improves prospects for in vivo human gene therapy. J. Virol. 70:4173-4178.
22. Gu, H., Y. R. Zou, and K. Rajewski. 1993. Independent control of immunoglobulin switch recombination at individual switch regions evidenced through Cre-loxP-mediated gene targeting. Cell 73:1155-1164.
23. Higgins, T., and E. Rosenquist (ed.). 1994. Stimulation of DNA synthesis in quiescent 3T3 cells. Academic Press, New York.
24. Hirano, T., and T. Kishimoto. 1990. Interleukin-6, p. 632-665. In M. B. Sporn and A. B. Roberts (ed.), Handbook of experimental pharmocology, vol. 95. Springer-Verlag KG, Heidelberg, Germany.
25. Hitt, M. M., and F. L. Graham. 1990. Adenovirus E1a under the control of heterologous promoter: wide variation in E1a expression levels has little effect on virus replication. Virology 179:667-678.
26. Hsu, W., and S. Cheng-Kiang. 1993. Convergent regulation of NF-IL-6 and Oct-1 synthesis by interleukin-6 and retinoic acid signaling in embryonal carcinoma cells. Mol. Cell. Biol. 13:2515-2523.
27. Imler, J. L., F. Dupuit, C. Chartier, N. Accart, A. Dieterle, H. Schultz, E. Puchelle, and A. Pavirani. 1996. Novel complementation cell lines derived from human lung carcinoma A549 cells support the growth of E1-deleted adenovirus vectors. Gene Ther. 3:75-84.
28. Imperiale, M. J., H.-T. Kao, L. T. Feldman, J. Nevins, and S. Strickland. 1984. Common control of the heat shock gene and early adenovirus genes: evidence of a cellular E1a-like activity. Mol. Cell. Biol. 4:867-874.
29. Jones, N., and T. Shenk. 1979. An adenovirus type 5 early function regulates expression of other early viral genes. Proc. Natl. Acad. Sci. USA 76:3665-3669.
30. Kay, M. A., F. Graham, F. Leland, and S. L. Woo. 1995. Therapeutic serum concentrations of human alpha-1-antitrypsin after adenoviral-mediated gene transfer into mouse hepatocytes. Hepatology 21:815-319.
31. Kay, M. A., A.-X. Holterman, L. Meuse, A. Gown, H. Ochs, P. S. Linsley, and C. B. Wilson. 1995. Long-term hepatic adenovirus mediated gene expression in mice following CTLA4Ig administration. Nature (London) Genet. 11:191-197.
32. Kay, M. A., Q. Li, T. J. Liu, F. Leland, C. Toman, M. Finegold, and S. L. Woo. 1992. Hepatic gene therapy: persistent expression of human alpha 1-antitrypsin in mice after direct gene delivery in vivo. Hum. Gene Ther. 3:641-647.
33. Krougliak, V., and F. L. Graham. 1995. Development of cell lines capable of complementing E1, E4, and protein IX defective adenovirus type 5 mutants. Hum. Gene Ther. 6:1575-1586.
34. La Thangue, N. B., and P. W. Rigby. 1987. An adenovirus E1a-like transcription factor is regulated during the differentiation of murine embryonal carcinoma stem cells. Cell 49:507-513.
35. Li, Q., M. A. Kay, M. Finegold, S. Perricaudet, and S. L. Woo. 1993. Assessment of recombinant adenoviral vectors for hepatic gene therapy. Hum. Gene Ther. 4:403-409.
36. Lieber, A., and M. A. Kay. 1996. Adenovirus-mediated expression of ribozymes in mice. J. Virol. 70:3153-3158.
37. Lieber, A., M. J. T. F. D. Vrancken-Peeters, and M. A. Kay. 1995. Adenovirus-mediated transfer of the amphpotropic retrovirus receptor c DNA increases retroviral transduction in cultured cells. Hum. Gene Ther. 6:5-11.
38. Matsumoto, K., M. Okuwaki, H. Kawase, H. Handa, F. Hanaoka, and K. Nagata. 1995. Stimulation of DNA transcription by the replication factor from the adenovirus genome in a chromatin-like structure. J. Biol. Chem. 270:9645-9650.
39. McCoy, R. D., B. L. Davidson, B. J. Roessler, G. B. Huffnagle, S. L. Janich, T. J. Laing, and R. H. Simon. 1995. Pulmonary inflammation induced by incomplete or inactivated adenoviral particles. Hum. Gene Ther. 6:1553-1560.
40. Mitani, K., F. L. Graham, C. T. Caskey, and S. Kochanek. 1995. Rescue, propagation, and partial purification of a helper virus-dependent adenovirus vector. Proc. Natl. Acad. Sci. USA 92:3854-3858.
41. Murphy, W. J., V. Kumar, and M. Bennett. 1989. Immunobiology of bone marrow transplantation: studies using SCID mice. Curr. Top. Microbiol. Immunol. 152:251-258.
42. Phelps, W. C., C. L. Yee, K. Munger, and P. M. Howley. 1988. The human papillomavirus type 16 E7 gene encodes transactivalion and transformation functions similar to those of adenovirus E1a. Cell 53:539-547.
43. Poli, V., F. P. Mancini, and R. Cortese. 1990. IL-6DBP, a nuclear protein involved in interleukine 6 signal transduction, defines a new family of leucine zipper related to C/EBP. Cell 63:643-653.
44. Rosenfeld, M. A., et al. 1992. In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell 68:143-155.
45. Sauer, B. 1993. Manipulation of transgenes by site-specific recombination: use of ere recombinase. Methods Enzymol. 225:890-900.
46. Sauer, B., and N. Henderson. 1988. Site-specific DNA recombination in mammalian cells by the Cre recombinase of bacteriophage P1. Proc. Natl. Acad. Sci. USA 85:5166-5170.
47. Sauer, B., and N. Henderson. 1989. Cre-stimulated recombination of loxP-containing DNA sequences placed into the mammalian genome. Nucleic Acids Res. 17:147-161.
48. Schneider-Gaedike, A., and E. Schwarz. 1986. Different human cervical carcinoma cell lines show similar transcription patterns of human papillomavirus type 18 early genes. EMBO J. 5:2285-2292.
49. Southern, P. J., and P. Berg. 1982. Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the early region promoter. J. Mol. Appl. Genet. 1:327-341.
50. Spergel, J. M., and S. Chen-Kiang. 1991. Interleukin 6 enhances a cellular activity that functionally substitutes for E1a protein in transactivation. Proc. Natl. Acad. Sci. USA 88:6472-6476.
51. Spergel, J. M., W. Hsu, S. Akira, B. Thimmappaya, T. Kishimoto, and S. Chen-Kiang. 1992. NF-IL6, a member of the C/EBP family, regulates E1a-responsive promoters in absence of E1a. J. Virol. 66:1021-1030.
52. Sternberg, N., and D. Hamilton. 1981. Bacteriophage P1 site-specific recombination. I. Recombination between loxP sites. J. Mol. Biol. 150:467-486.
53. Sussenbach, J. S., and P. C. Van Der Vliet. 1973. Studies on the mechanism of replication of adenovirus DNA. I. The effects of hydroxyurea. Virology 54:299-303.
54. Van der Vliet, P. C. 1995. Adenovirus DNA replication, p. 1-31. In W. Doerfler and P. Bohm (ed.), The molecular repertoire of adenoviruses, vol. 2. Molecular biology of virus-cell interactions. Springer-Verlag, Berlin.
55. Vrancken-Peeters, M. J. T. F. D., A. Lieber, J. Perkins, and M. A. Kay. 1996. A method for multiple portal vein infusions in mice: quantitation of adenovirus-mediated hepatic gene transfer. BioTechniques. 20:278-285.
56. Wang, Q., X. Jia, and M. H. Finer. 1995. A packaging cell line for propagation of recombinant adenovirus vectors containing two lethal gene-region deletions. Gene Ther. 2:775-783.
57. Wegner, M., Z. Cao, and M. Rosenfeld. 1992. Calcium-regulated phosphorylation within the leucine zipper of C/EBPb. Science 256:370-373.
58. Wong, M. L., and M. T. Hsu. 1988. Psoralen-cross-linking study of the organization of intercellular adenovirus nucleoprotein complexes. J. Virol. 62:1227-1234.
59. Wong, M. L., and M. T. Hsu. 1989. Linear adenovirus DNA is organized into supercoiled domains in virus particles. Nucleic Acids Res. 17:3536-3550.
60. Wrighton, C. J., R. Hofer-Warbinek, T. Moll, R. Eytner, F. H. Bach, and R. de Martin. 1996. Inhibition of endothelial cell activation by adenovirus-mediated expression of IkBalpha, an inhibitor of the transcription factor NF-kB. J. Exp. Med. 183:1013-1022.
61. Yang, Y., H. C. J. Ertl, and J. M. Wilson. 1995. Cellular and humoral immune response to viral antigens created barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 59:2004-2015.
62. Yang, Y., F. A. Nunes, K. Berencsi, E. E. Furth, E. Gonczol, and J. M. Wilson. 1994. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. USA 91:4407-4411.
63. Yang, Y., F. A. Nunes, K. Berencsi, E. Gonczol, J. F. Engelhardt, and J. M. Wilson. 1994. Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis. Nature (London) Genet. 7:362-369.
64. Yang, Y., G. Trinchieri, and J. M. Wilson. 1995. Recombinant IL-12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung. Nature (London) Med. 1:890-893.
65. Zabner, J., L. A. Couture, R. J. Gregory, S. M. Graham, A. E. Smith, and M. J. Welsh. 1993. Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis. Cell 75:207-216.
66. Zhou, H., W. O'Neal, N. Murral, and A. L. Beaudet. 1996. Development of a complementing cell line and a system for construction of adenovirus vectors with E1 and E2a deleted. J. Virol. 70:7030-7038.